Laser Weapons Are Real Now — Here's What It Means for Defense Stocks
Directed-energy weapons are moving from labs to battlefields, reshaping the math for defense investors eyeing counterdrone plays.
Laser weapons aren't a Hollywood prop anymore. They're being deployed, they're taking down drones, and they're forcing a hard reset on how you value defense stocks. If you're still thinking about this sector the old way — missiles, contracts, slow burn — you're already behind.
The counterdrone market is exploding, and it's not hard to see why. Cheap commercial drones have become a serious battlefield threat, and the traditional intercept model — shooting a $50,000 missile at a $500 drone — is fiscally absurd. Directed-energy systems flip that equation. A laser shot costs pennies on the dollar compared to a kinetic kill. That changes the unit economics of modern warfare entirely.
Read more BoE's Mann: Fewer Rate Hike Bets Are Why She'd Hike More →
MarketWatch flags Palantir and Elbit as two names worth watching in this space. Palantir brings the AI and data-integration layer that makes smart targeting possible at scale. Elbit, the Israeli defense giant, has deep operational experience in exactly the kind of contested airspace where these systems get stress-tested in real conditions — not just test ranges. That real-world pedigree matters to procurement officers writing big checks.
The tradeable angle here is timing. Defense budgets globally are rising, drone threats aren't going away, and governments are under pressure to find cost-effective countermeasures fast. Companies positioned at the intersection of AI-driven targeting and directed energy aren't just riding a trend — they're selling the solution to a problem that gets worse every quarter. That's a durable demand story, not a one-quarter pop.
Don't sleep on how quickly this technology is maturing. What looked like a decade-away capability is now fielded hardware. The stocks that move fastest will be the ones the market hasn't fully re-rated yet. Continue reading at MarketWatch.com
